April was a good month for PMS schemes, with 198 of the 232 schemes under consideration outperforming the Nifty50. The schemes returned 2.8% on average, better than the -0.4% given by the benchmark.
Better-performing strategies in April included Kotak’s Pharma fund (13.4%), Sageone’s Small and Microcap fund (12.7%), and Anvil Wealth Management’s Long Holding Strategy (12.4%), the data from PMS Bazaar showed. Large-cap PMS schemes (average returns of 0.5%), mid-cap schemes (2.8%), multi-cap schemes (2.6%), and small-cap (6.4%) all outperformed their respective category benchmark indices.
Returns were calculated on a time-weighted rate of return basis for the schemes under consideration.
The time-weighted rate